U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584265) titled 'Engagement Study for Participants With Factor V Leiden and Prothrombin G20210A Mutations' on March 04.
Brief Summary: This study will enrol individuals who have, or may have, Factor V Leiden or Prothrombin G20210A mutations, which are genetic changes linked to an increased risk of blood clots. Targeted genetic testing will be carried out, where appropriate, to confirm whether participants have one of these genetic variants. Those with a confirmed result will attend a site visit for basic health checks, including blood pressure measurements, ECG, and blood tests, to establish a baseline of their general health and help identify suitab...